(1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase

被引:192
作者
Bielawska, A
Greenberg, MS
Perry, D
Jayadev, S
Shayman, JA
McKay, C
Hannun, YA
机构
[1] DUKE UNIV, MED CTR, DEPT MED, DURHAM, NC 27710 USA
[2] DUKE UNIV, MED CTR, DEPT PEDIAT, DURHAM, NC 27710 USA
[3] UNIV MICHIGAN, MED CTR, DEPT MED, ANN ARBOR, MI 48109 USA
关键词
D O I
10.1074/jbc.271.21.12646
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we have examined the cellular and biochemical activities of the ceramide analog (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol (D-erythro-MAPP). Addition of 5 mu M D-e-MAPP to HL-60 human promyelocytic leukemia cells resulted in a concentration- and time-dependent growth suppression accompanied by an arrest in the G(0)/G(1) phase of the cell cycle; thus mimicking the action of exogenous ceramides. Its enantiomer L-e-MAPP was without effect. Two lines of evidence suggested that D-e-MAPP may not function as a direct analog of ceramide. First, D-e-MAPP possesses a stereochemical configuration opposite to that of D-erythro-ceramide. Second, D-e-MAPP failed to activate ceramide-activated protein phosphatase in vitro. Therefore, we examined if D-e-MAPP functioned indirectly by modulating endogenous ceramide levels. The addition of D-e-MAPP to cells, but not L-e-MAPP, caused a time- and concentration-dependent elevation in endogenous ceramide levels reaching greater than 3-fold over base-line following 24 h of treatment. Both D-e-MAPP and L-e-MAPP underwent similar uptake by HL-60 cells. D-e-MAPP was poorly metabolized, and remained intact in cells, whereas L-e-MAPP underwent a time- and concentration-dependent metabolism; primarily through N-deacylation. In vitro, L-e-MAPP was metabolized by alkaline ceramidase to an extent similar to that seen with C-16-ceramide, D-e-MAPP was not metabolized. Instead, D-e-MAPP inhibited alkaline ceramidase activity in vitro with an IC50 of 1-5 mu M. D-e-MAPP did not modulate the activity of other ceramide metabolizing enzymes in vitro or in cells, and it was a poor inhibitor of acid ceramidase (IC50 > 500 mu M). Finally, D-e-MAPP inhibited the metabolism of L-e-MAPP in cells. These studies demonstrate that D-e-MAPP functions as an inhibitor of alkaline ceramidase in vitro and in cells resulting in elevation in endogenous levels of ceramide with the consequent biologic effects of growth suppression and cell cycle arrest. These studies point to an important role for ceramidases in the regulation of endogenous levels of ceramide.
引用
收藏
页码:12646 / 12654
页数:9
相关论文
共 69 条
  • [1] IMPROVED INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE
    ABE, A
    INOKUCHI, J
    JIMBO, M
    SHIMENO, H
    NAGAMATSU, A
    SHAYMAN, JA
    SHUKLA, GS
    RADIN, NS
    [J]. JOURNAL OF BIOCHEMISTRY, 1992, 111 (02) : 191 - 196
  • [2] BALLOU LR, 1992, J BIOL CHEM, V267, P20044
  • [3] GLYCOLIPID DEPLETION USING A CERAMIDE ANALOG (PDMP) ALTERS GROWTH, ADHESION, AND MEMBRANE LIPID ORGANIZATION IN HUMAN A431 CELLS
    BARBOUR, S
    EDIDIN, M
    FELDINGHABERMANN, B
    TAYLORNORTON, J
    RADIN, NS
    FENDERSON, BA
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1992, 150 (03) : 610 - 619
  • [4] PURIFICATION, CHARACTERIZATION, AND BIOSYNTHESIS OF HUMAN ACID CERAMIDASE
    BERNARDO, K
    HURWITZ, R
    ZENK, T
    DESNICK, RJ
    FERLINZ, K
    SCHUCHMAN, EH
    SANDHOFF, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) : 11098 - 11102
  • [5] BIELAWSKA A, 1993, J BIOL CHEM, V268, P26226
  • [6] MODULATION OF CELL-GROWTH AND DIFFERENTIATION BY CERAMIDE
    BIELAWSKA, A
    LINARDIC, CM
    HANNUN, YA
    [J]. FEBS LETTERS, 1992, 307 (02) : 211 - 214
  • [7] BIELAWSKA A, 1992, J BIOL CHEM, V267, P18493
  • [8] BUEHRER BM, 1993, ADV LIPID RES, V26, P59
  • [9] CARTER HE, 1956, J BIOL CHEM, V221, P879
  • [10] CERAMIDE - A POTENTIAL 2ND-MESSENGER IN THE NERVOUS-SYSTEM
    CHAO, MV
    [J]. MOLECULAR AND CELLULAR NEUROSCIENCE, 1995, 6 (02) : 91 - 96